Evolution of the Average Target: DaShenLin Pharmaceutical Group Co., Ltd.

Evolution of the Average Target - DaShenLin Pharmaceutical Group Co., Ltd.

Evolution of the Target Price: DaShenLin Pharmaceutical Group Co., Ltd.

Evolution of the Target Price - DaShenLin Pharmaceutical Group Co., Ltd.

Changes in Analyst Recommendations: DaShenLin Pharmaceutical Group Co., Ltd.

4.oM4woEdoq3nDQRHwMTmFXOH5voa3a5NmOV-ep2dtJ5Y.mfZnyRVc80ymO1CJCAjBZamaytzvXfpLbhTKnwwFUcT3gkjHJQDYG7AOeg~e7f6a9a80a236af90be668f028efa373

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+16.74%
+96.88%
+7.88%
+5.22%
+69.6%
+22.92%
+70.31%
+12.76%
+22.82%
+17.54%
Average +34.27%
Weighted average by Cap. +43.23%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
20.58CNY
Average target price
24.02CNY
Spread / Average Target
+16.74%
High Price Target
26.80CNY
Spread / Highest target
+30.22%
Low Price Target
15.00CNY
Spread / Lowest Target
-27.11%

Analyst Consensus Detail

Analyst consensus - DaShenLin Pharmaceutical Group Co., Ltd.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - DaShenLin Pharmaceutical Group Co., Ltd.
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - DaShenLin Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 603233 Stock
  4. Consensus DaShenLin Pharmaceutical Group Co., Ltd.